Home › Cerebral Palsy › NCT06040619
Implementation of Therapy Together
Implementation of Therapy Together With the State of Texas Early Childhood Intervention Program
Who can join
3 Months – 71 Months · All sexes
Full eligibility criteria
Inclusion Criteria: * at risk for developing cerebral palsy or have been diagnosed with cerebral palsy * children ages 3 months to 5 years 11 months * present with asymmetric hand use * present with a unilateral upper limb impairment * able to visually attend to objects * demonstrate an interest in objects * attempt to reach for or grasp objects with the impaired upper extremity Exclusion Criteria: * uncontrolled epilepsy * significant visual impairment * severe behavioral problems * inability to complete the assessment protocol.
About the study
The goal of this clinical trial is to learn about the implementation of Therapy Together, a pediatric constraint-induced movement therapy program in young children with unilateral cerebral palsy. The main question\[s\] it aims to answer are:
* Is the Therapy Together program effective in improving hand function and occupational performance compared to usual care? * Is it feasible to implement the Therapy Together program within the standard care, early intervention framework?
Participants will participate in an 8-week pediatric constraint-induced movement therapy program. Researchers will compare the group completing the Therapy Together Program to a group that is receiving usual care to see if there is a difference in the change in hand function, occupational performance, and development.
What is being tested
- Therapy Together (behavioral)
- Usual Care (behavioral)
Sponsor: Texas Scottish Rite Hospital for Children · Participants: 30 · Started: Nov 13, 2023
Contact the study team
- Angela Shierk, PhD · Phone: (469) 412-7172
- Heather Roberts, PhD · Phone: (214) 794-8117
Official record on ClinicalTrials.gov — NCT06040619
Locations in the U.S.
| Texas | Scottish Rite for Children, Frisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.